Title

Have we reached proton beam therapy dosimetric limitations?–A novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer

Document Type

Letter to the Editor

Publication Date

3-4-2018

This document is currently not available here.

Share

COinS